Nuvalent Inc - Ordinary Shares - Class A

NASDAQ:NUVL   4:00:00 PM EDT
67.20
-0.40 (-0.59%)
7:32:44 PM EDT: $64.21 -2.99 (-4.45%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Nuvalent Inc - Ordinary Shares - Class A Stock, NASDAQ:NUVL

One Broadway, 14th floor, Cambridge, Massachusetts 02142
United States of America
Phone: +1.857.357.7000
Number of Employees: 92
http://www.nuvalent.com

Description

Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC. The company was founded by Matthew D. Shair in January 2017 and is headquartered in Cambridge, MA.